NCT06859853View on ClinicalTrials.gov

A Study to Evaluate MWN109 Injection in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

September 25, 2025

Study Completion Date

November 25, 2025

Conditions
Overweight or Obese
Interventions
DRUG

Placebo

Sub cutaneous injection on the abdomen by a qualified member of study staff.

DRUG

Subcutaneous single and mutiple dose

Sub cutaneous injection on the abdomen by a qualified member of study staff.

Trial Locations (1)

3153

RECRUITING

Veritus Research, Melbourne

All Listed Sponsors
lead

Shanghai Minwei Biotechnology Co., Ltd

INDUSTRY